Pharvaris Income Statement (2019-2026) | PHVS

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024 Mar2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) -32.52M-35.31M
Selling, General & Administrative (Quarter) -11.86M-16.52M
Operating Expenses (Quarter) -44.38M-51.83M
Operating Income (Quarter) -44.38M-51.83M
EBIT (Quarter) -44.38M-51.83M
Non-operating items
Other Non Operating Income (Quarter) 5.67M-4.82M
Non Operating Income (Quarter) -1.23M6.26M
Net income details
EBT (Quarter) -48.43M-45.57M
Profit After Tax (Quarter) -48.75M-45.89M
Income from Continuing Operations (Quarter) -48.43M-45.57M
Consolidated Net Income (Quarter) -48.43M-45.57M
Income towards Parent Company (Quarter) -48.88M-45.78M
Net Income towards Common Stockholders (Quarter) -48.88M-45.78M
Additional items
EPS (Basic) (Quarter) -4.98
Shares Outstanding (Weighted Average) (Quarter) 0.14M6.25M4.58M4.18M6.78M6.95M9.11M9.19M
EBITDA (Quarter) -44.38M-51.83M